Etiology of Cochlosomiasis in Turkeys and Ducks
By light microscopy, Cochlosoma anatis is 6–12 micrometers (mcm) long and 4–7 mcm wide, with a characteristic adhesive disc on the anteroventral surface of its pyriform body. It moves in a jerking motion. This protozoan has a single nucleus and uses flagella for movement. Lateral transmission has been observed with turkeys, but direct contact of the birds was necessary for infection. PCR has detected C anatis on house flies, but no studies have demonstrated them as carrying live trophozoites.
Clinical Findings of Cochlosomiasis in Turkeys and Ducks
There is a debate on the pathogenicity of C anatis in avian species. The exact role of this parasite is unknown, because coinfection of viruses, bacteria and other protozoans with C anatis has led to gastrointestinal distress whereas infection with this protozoan alone does not always lead to clinical signs. Scanning electron microscopy has shown C anatis attaching to intestinal mucosa; however, no visual changes in the intestines have been observed under light microscopy with the protozoan present.
Diagnosis of Cochlosomiasis in Turkeys and Ducks
Light microscopy and PCR are used to identify Cochlosoma anatis in intestinal scrapings and feces. Analysis of samples within two minutes of collection is recommended for proper identification because C anatis becomes immobile when cooled.
Prevention and Treatment of Cochlosomiasis in Turkeys and Ducks
Wild birds, small rodents, and multi-aged flocks have been identified as carriers of C anatis. Proper biosecurity Biosecurity prevents the entry of this parasite to poultry flocks. Disinfection of housing facilities after an outbreak is necessary to prevent contamination of future flocks. Nitroimidazole and nitarsone have been proven as successful treatments for C anatis, but unfortunately these products are not approved in commercial poultry.
C anatis is a flagellated protozoan that has debatable pathogenicity in avian species.
Intestinal scrapings and fecal material can be used for identification.
No treatments are currently available for cochlosomiasis.